AI-native · Full-service CRO
Reduce clinical programming time by up to 90% with SPARC AI.
K3 is the AI-native, full-service CRO. Senior clinical teams run your study end to end — and SPARC, the AI platform we built, compresses biometrics from months to days, protocol to submission.
Services
Every discipline your study needs. One accountable team.
The full breadth of biometrics, clinical operations, and safety — each discipline its own senior practice, all under one roof.
Why K3
The reasons sponsors stay.
Every CRO promises quality and speed. Here's what that looks like at K3.
The team that starts, finishes
92% employee retention means the statistician who scopes your study is there at submission. 100% client retention means it shows.
Compliance, by design
Systems designed and validated to support 21 CFR Part 11, with training records maintained across all 50 states — see how we run quality.
Speed, when you choose it
Our own automation platform can compress biometrics from months to days — an option on any engagement, never a requirement.
No surprises
Live delivery visibility — you see what we see, for the life of the study.
Why K3 is not a standard CRO
The same study, run two ways.
Most CROs still run trials on spreadsheets, disconnected specs, and manual handoffs. K3 runs them on software we built — AI-driven, FSP-native, end to end.
Technology
Software we built, because your timeline deserved better.
K3 develops and operates its own clinical technology — run on our own business before it touches your study. For you, that means options most CROs can't offer. None of them are ever a requirement.
Explore our platformsSame rigor, same review gates — automation removes the waiting, not the oversight. About SPARC →
The platform behind the people
One operating system behind every study.
Senior teams do the work. Software K3 built and operates makes it fast, visible, and auditable — an option on any engagement, never a requirement.
The standards our work is built to
Case studies
How it comes together on a real study.
Teams and platforms, working the way they were built to.
A stalled Phase III oncology submission, back on timeline in weeks
A mid-size sponsor inherited a delayed biometrics package from a departing vendor eight weeks before a planned submission. K3 assumed scope without resetting the clock.
One functional partner across a growing program portfolio
A sponsor consolidating from five point vendors to a single functional partner needed capacity that could scale across studies without re-contracting.
Inspection-ready staffing across 50 states, provable in one click
A sponsor's site network spanned dozens of states with differing training requirements. Proving every K3 professional was current had been a manual, weeks-long exercise before each audit.
Insights
From our teams, in practice.
White Paper · 2025
Harnessing LLM-Augmented Automation for ADaM Dataset Generation with Admiral
A metadata-driven, LLM-augmented pipeline for ADaM dataset generation inside SPARC — embedding CDISC standards and admiral/pharmaverse best practices to guide LLMs toward regulator-ready R code.
Read →White Paper · January 2025
Risk-Based Monitoring in Clinical Trials and SPARC’s AI/ML Capabilities
A deep dive into Risk-Based Monitoring and how SPARC's AI/ML capabilities operationalize it — from KRIs and QTLs to central statistical monitoring and real-time risk dashboards.
Read →White Paper · 2025
SPARC AI: A Native Metadata-Driven Engine for End-to-End Clinical Trial Analysis
A hybrid, metadata-native clinical trial automation platform that combines deterministic metadata-based engines with LLM-augmented intelligence — CDISC-aware, traceable, and audit-ready.
Read →Tell us about your study. We'll bring a plan.
A full program, one deliverable under pressure, or a second opinion on a timeline — we respond promptly, with named people and a scoped approach.
Contact K3